Skip to main content
SpringerLink
Log in

Retroperitoneal and Abdominal Lesions Laser Ablation

  • Chapter
  • First Online:
Image-guided Laser Ablation

  • 504 Accesses

Abstract

Laser ablation (LA) has been reported to be a minimally invasive and extremely well-tolerated procedure without serious complications in several anatomical structures. It has been shown that percutaneous LA is tolerable in patients in unfavorable general conditions or in patients with lesions at high-risk sites because of the use of very thin devices and precise energy application. LA guided by ultrasound and/or computed tomography through the percutaneous or endoscopic approach has been reported to be a feasible procedure and can be considered as a new weapon for retroperitoneal and peritoneal lesions, and also for abdominal pathological lymph nodes. In this chapter, the possible application of LA in the treatment of retroperitoneal and peritoneal lesions and abdominal lymph nodes will be presented and discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 89.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Allan PLP. Clinical ultrasound. Edinburgh: Churchill Livingstone; 2011.

    Google Scholar 

  2. Yun M, Zhao Q, Zhong L, Chen F, Jiang T. Preliminary results of ultrasound-guided laser ablation for unresectable metastases to retroperitoneal and hepatic portal lymph nodes. World J Surg Oncol. 2016;14:165.

    Article  Google Scholar 

  3. Wong SL, Mangu PB, Choti MA, Crocenzi TS, Dodd GD 3rd, Dorfman GS, et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepatic metastases from colorectal cancer. J Clin Oncol. 2010;28(3):493–508.

    Article  Google Scholar 

  4. Shyn PB, Mauri G, Alencar RO, Tatli S, Shah SH, Morrison PR, et al. Percutaneous imaging-guided cryoablation of liver tumors: predicting local progression on 24-hour MRI. AJR Am J Roentgenol. 2014;203(2):W181–91.

    Article  Google Scholar 

  5. Zampino MG, Magni E, Ravenda PS, Cella CA, Bonomo G, Della Vigna P, et al. Treatments for colorectal liver metastases: a new focus on a familiar concept. Crit Rev Oncol Hematol. 2016;108:154–63.

    Article  CAS  Google Scholar 

  6. Monfardini L, Orsi F, Caserta R, Sallemi C, Della Vigna P, Bonomo G, et al. Ultrasound and cone beam CT fusion for liver ablation: technical note. Int J Hyperth. 2018, 35:1–5.

    Article  Google Scholar 

  7. Mauri G, Nicosia L, Varano GM, Shyn P, Sartori S, Tombesi P, et al. Unusual tumour ablations: report of difficult and interesting cases. Ecancermedicalscience. 2017;11:733.

    Article  Google Scholar 

  8. Mauri G, Cova L, De Beni S, Ierace T, Tondolo T, Cerri A, et al. Real-time US-CT/MRI image fusion for guidance of thermal ablation of liver tumors undetectable with US: results in 295 cases. Cardiovasc Intervent Radiol. 2015;38(1):143–51.

    Article  Google Scholar 

  9. Mainini AP, Monaco C, Pescatori LC, De Angelis C, Sardanelli F, Sconfienza LM, et al. Image-guided thermal ablation of benign thyroid nodules. J Ultrasound. 2017;20(1):11–22.

    Article  Google Scholar 

  10. D’Onofrio M, Ciaravino V, De Robertis R, Barbi E, Salvia R, Girelli R, et al. Percutaneous ablation of pancreatic cancer. World J Gastroenterol. 2016;22(44):9661–73.

    Article  Google Scholar 

  11. Pacella CM, Stasi R, Bizzarri G, Pacella S, Graziano FM, Guglielmi R, et al. Percutaneous laser ablation of unresectable primary and metastatic adrenocortical carcinoma. Eur J Radiol. 2008;66(1):88–94.

    Article  Google Scholar 

  12. Pacella CM, Valle D, Bizzarri G, Pacella S, Brunetti M, Maritati R, et al. Percutaneous laser ablation in patients with isolated unresectable liver metastases from colorectal cancer: results of a phase II study. Acta Oncol. 2006;45(1):77–83.

    Article  Google Scholar 

  13. Pacella CM, Francica G, Di Lascio FM, Arienti V, Antico E, Caspani B, et al. Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysis. J Clin Oncol. 2009;27(16):2615–21.

    Article  Google Scholar 

  14. Pacella CM, Mauri G, Achille G, Barbaro D, Bizzarri G, De Feo P, et al. Outcomes and risk factors for complications of laser ablation for thyroid nodules: a multicenter study on 1531 patients. J Clin Endocrinol Metab. 2015;100(10):3903–10.

    Article  CAS  Google Scholar 

  15. Tombesi P, Di Vece F, Sartori S. Laser ablation for hepatic metastases from neuroendocrine tumors. AJR Am J Roentgenol. 2015;204(6):W732.

    Article  Google Scholar 

  16. Mauri G, Cova L, Ierace T, Baroli A, Di Mauro E, Pacella CM, et al. Treatment of metastatic lymph nodes in the neck from papillary thyroid carcinoma with percutaneous laser ablation. Cardiovasc Intervent Radiol. 2016;39(7):1023–30.

    Article  Google Scholar 

  17. Pacella CM, Mauri G, Cesareo R, Paqualini V, Cianni R, De Feo P, et al. A comparison of laser with radiofrequency ablation for the treatment of benign thyroid nodules: a propensity score matching analysis. Int J Hyperth. 2017;33(8):911–9.

    Google Scholar 

  18. Patelli G, Ranieri A, Paganelli A, Mauri G, Pacella CM. Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Cardiovasc Intervent Radiol. 2017;40(9):1440–6.

    Article  Google Scholar 

  19. Sartori S, Mauri G, Tombesi P, Di Vece F, Bianchi L, Pacella CM. Ultrasound-guided percutaneous laser ablation is safe and effective in the treatment of small renal tumors in patients at increased bleeding risk. Int J Hyperth. 2018;35(1):19–25.

    Article  Google Scholar 

  20. Mauri G, Nicosia L, Della Vigna P, Varano GM, Maiettini D, Bonomo G, et al. Percutaneous laser ablation for benign and malignant thyroid diseases. Ultrasonography. 2019;38(1):25–36.

    Article  Google Scholar 

  21. Artifon EL, Franzini TA, Kumar A, Matsura PF, Furuya CK Jr, Ishioka S, et al. EUS-guided FNA facilitates the diagnosis of retroperitoneal endometriosis. Gastrointest Endosc. 2007;66(3):620–2.

    Article  Google Scholar 

  22. Tian G, Bao H, Li J, Jiang T. Systematic review and meta-analysis of diagnostic accuracy of endoscopic ultrasound (EUS)-guided fine-needle aspiration (FNA) using 22-gauge and 25-gauge needles for pancreatic masses. Med Sci Monit. 2018;24:8333–41.

    Article  Google Scholar 

  23. Park JK, Song BJ, Ryu JK, Paik WH, Park JM, Kim J, et al. Clinical outcomes of endoscopic ultrasonography-guided pancreatic cyst ablation. Pancreas. 2016;45(6):889–94.

    Article  Google Scholar 

  24. Paik WH, Seo DW, Dhir V, Wang HP. Safety and efficacy of EUS-guided ethanol ablation for treating small solid pancreatic neoplasm. Medicine (Baltimore). 2016;95(4):e2538.

    Article  CAS  Google Scholar 

  25. Hu YH, Tuo XP, Jin ZD, Liu Y, Guo Y, Luo L. Endoscopic ultrasound (EUS)-guided ethanol injection in hepatic metastatic carcinoma: a case report. Endoscopy. 2010;42(Suppl 2):E256–7.

    Article  Google Scholar 

  26. Di Matteo F, Grasso R, Pacella CM, Martino M, Pandolfi M, Rea R, et al. EUS-guided Nd:YAG laser ablation of a hepatocellular carcinoma in the caudate lobe. Gastrointest Endosc. 2011;73(3):632–6.

    Article  Google Scholar 

  27. Nakaji S, Hirata N, Iwaki K, Shiratori T, Kobayashi M, Inase M. Endoscopic ultrasound (EUS)-guided ethanol injection for hepatocellular carcinoma difficult to treat with percutaneous local treatment. Endoscopy. 2012;44(Suppl 2 UCTN):E380.

    PubMed  Google Scholar 

  28. Di Matteo F, Picconi F, Martino M, Pandolfi M, Pacella CM, Schena E, et al. Endoscopic ultrasound-guided Nd:YAG laser ablation of recurrent pancreatic neuroendocrine tumor: a promising revolution? Endoscopy. 2014;46(Suppl 1 UCTN):E380–1.

    PubMed  Google Scholar 

  29. Zhang WY, Li ZS, Jin ZD. Endoscopic ultrasound-guided ethanol ablation therapy for tumors. World J Gastroenterol. 2013;19(22):3397–403.

    Article  CAS  Google Scholar 

  30. Yoon WJ, Brugge WR. Endoscopic ultrasonography-guided tumor ablation. Gastrointest Endosc Clin N Am. 2012;22(2):359–69, xi.

    Article  Google Scholar 

  31. Jiang TA, Deng Z, Tian G, Zhao QY, Wang WL. Efficacy and safety of endoscopic ultrasonography-guided interventional treatment for refractory malignant left-sided liver tumors: a case series of 26 patients. Sci Rep. 2016;6:36098.

    Article  CAS  Google Scholar 

  32. Ji YB, Varadarajulu S. Endoscopic ultrasound-guided management of pancreatic pseudocysts and walled-off necrosis. Clin Endosc. 2014;47:429–43.

    Article  Google Scholar 

  33. Wang Z, Lu J, Gong J, Zhang L, Xu Y, Song S, et al. CT-guided radioactive 125I seed implantation therapy of symptomatic retroperitoneal lymph node metastases. Cardiovasc Intervent Radiol. 2014;37(1):125–31.

    Article  Google Scholar 

  34. Artifon EL, Lucon AM, Sakai P, Gerhardt R, Srougi M, Takagaki T, et al. EUS-guided alcohol ablation of left adrenal metastasis from non-small-cell lung carcinoma. Gastrointest Endosc. 2007;66(6):1201–5.

    Article  Google Scholar 

  35. Mou Y, Zhao Q, Zhong L, Chen F, Jiang T. Preliminary results of ultrasound-guided laser ablation for unresectable metastases to retroperitoneal and hepatic portal lymph nodes. World J Surg Oncol. 2016;14(1):165.

    Article  Google Scholar 

  36. Jiang T, Deng Z, Tian G, Chen F, Bao H, Li J, et al. Percutaneous laser ablation: a new contribution to unresectable high-risk metastatic retroperitoneal lesions? Oncotarget. 2017;8(2):2413–22.

    PubMed  Google Scholar 

  37. Tian G, Jiang T. US-guided percutaneous laser ablation of refractory metastatic retroperitoneal lesions: a care-compliant case report. Medicine (Baltimore). 2017;96(15):e6597.

    Article  Google Scholar 

  38. Jiang T, Chai W. Endoscopic ultrasonography (EUS)-guided laser ablation (LA) of adrenal metastasis from pancreatic adenocarcinoma. Lasers Med Sci. 2018;33(7):1613–6.

    Article  Google Scholar 

  39. Arellano RS, Flanders VL, Lee SI, Mueller PR, Gervais DA. Imaging-guided percutaneous radiofrequency ablation of retroperitoneal metastatic disease in patients with gynecologic malignancies: clinical experience with eight patients. AJR Am J Roentgenol. 2010;194(6):1635–8.

    Article  Google Scholar 

  40. Gao F, Gu Y, Huang J, Zhao M, Wu P. Radiofrequency ablation of retroperitoneal metastatic lymph nodes from hepatocellular carcinoma. Acad Radiol. 2012;19(8):1035–40.

    Article  Google Scholar 

  41. Littrup PJ, Bang HJ, Currier BP, Goodrich DJ, Aoun HD, Heilbrun LK, et al. Soft-tissue cryoablation in diffuse locations: feasibility and intermediate term outcomes. J Vasc Interv Radiol. 2013;24(12):1817–25.

    Article  Google Scholar 

  42. Mu F, Niu L, Li H, Liao M, Li L, Liu C, et al. Percutaneous comprehensive cryoablation for metastatic hepatocellular cancer. Cryobiology. 2013;66(1):76–80.

    Article  CAS  Google Scholar 

  43. Li J, Fan W, Niu L, Yang JY. Percutaneous computed tomography-guided cryoablation for recurrent malignant primary retroperitoneal tumors: initial experience of 39 patients. J Vasc Interv Radiol. 2016;27:S81.

    Article  Google Scholar 

  44. Underhill CE, Walsh NJ, Bateson BP, Mentzer C, Kruse EJ. Feasibility and safety of irreversible electroporation in locally advanced pelvic and retroperitoneal tumors. Am Surg. 2016;82(9):e263–5.

    PubMed  Google Scholar 

  45. Araujo LH, Gouveia HR, Freitas Ede Q, Pedras FV, Luz JH. Hepatic transarterial chemoembolization and retroperitoneal lymph node radiofrequency ablation in the multidisciplinary approach of an overt metastatic leiomyosarcoma. Cancer Imaging. 2013;13:123–7.

    Article  Google Scholar 

  46. Gervais DA, Arellano RS, Mueller PR. Percutaneous radiofrequency ablation of nodal metastases. Cardiovasc Intervent Radiol. 2002;25(6):547–9.

    Article  Google Scholar 

  47. Zhao M, Li X, Wang J, Li W, Huang Z. Retroperitoneal schwannoma treated with percutaneous computed tomography-guided radiofrequency ablation. J Neurosurg Spine. 2012;17(2):173–6.

    Article  Google Scholar 

  48. Keil S, Bruners P, Brehmer B, Mahnken AH. Percutaneous radiofrequency ablation for treatment of recurrent retroperitoneal liposarcoma. Cardiovasc Intervent Radiol. 2008;31(Suppl 2):S213–6.

    Article  Google Scholar 

  49. Monfardini L, Varano GM, Foa R, Della Vigna P, Bonomo G, Orsi F. Local recurrence of renal cancer after surgery: prime time for percutaneous thermal ablation? Cardiovasc Intervent Radiol. 2015;38(6):1542–7.

    Article  Google Scholar 

  50. Molina R, Alvarez M, Capilla J, Paez A. Radiofrequency-treated recurrence of urothelial carcinoma of the upper urinary tract after nephroureterectomy. Korean J Urol. 2014;55(12):844–6.

    Article  Google Scholar 

  51. Carrafiello G, Lagana D, Recaldini C, Giorgianni A, Ianniello A, Lumia D, et al. Imaging-guided percutaneous radiofrequency ablation of adrenal metastases: preliminary results at a single institution with a single device. Cardiovasc Intervent Radiol. 2008;31(4):762–7.

    Article  CAS  Google Scholar 

  52. Welch BT, Callstrom MR, Carpenter PC, Wass CT, Welch TL, Boorjian SA, et al. A single-institution experience in image-guided thermal ablation of adrenal gland metastases. J Vasc Interv Radiol. 2014;25(4):593–8.

    Article  Google Scholar 

  53. Wood BJ, Abraham J, Hvizda JL, Alexander HR, Fojo T. Radiofrequency ablation of adrenal tumors and adrenocortical carcinoma metastases. Cancer. 2003;97(3):554–60.

    Article  Google Scholar 

  54. Arienti V, Pretolani S, Pacella CM, Magnolfi F, Caspani B, Francica G, et al. Complications of laser ablation for hepatocellular carcinoma: a multicenter study. Radiology. 2008;246(3):947–55.

    Article  Google Scholar 

  55. Pacella CM, Bizzarri G, Francica G, Bianchini A, De Nuntis S, Pacella S, et al. Percutaneous laser ablation in the treatment of hepatocellular carcinoma with small tumors: analysis of factors affecting the achievement of tumor necrosis. J Vasc Interv Radiol. 2005;16(11):1447–57.

    Article  Google Scholar 

  56. Di Costanzo GG, D’Adamo G, Tortora R, Zanfardino F, Mattera S, Francica G, et al. A novel needle guide system to perform percutaneous laser ablation of liver tumors using the multifiber technique. Acta Radiol. 2013;54(8):876–81.

    Article  Google Scholar 

  57. Di Costanzo GG, Francica G, Pacella CM. Laser ablation for small hepatocellular carcinoma: state of the art and future perspectives. World J Hepatol. 2014;6(10):704–15.

    Article  Google Scholar 

  58. Caspani B, Ierardi AM, Motta F, Cecconi P, Fesce E, Belli L. Small nodular hepatocellular carcinoma treated by laser thermal ablation in high risk locations: preliminary results. Eur Radiol. 2010;20(9):2286–92.

    Article  Google Scholar 

  59. Francica G, Petrolati A, Di Stasio E, Pacella S, Stasi R, Pacella CM. Effectiveness, safety, and local progression after percutaneous laser ablation for hepatocellular carcinoma nodules up to 4 cm are not affected by tumor location. AJR Am J Roentgenol. 2012;199(6):1393–401.

    Article  Google Scholar 

  60. Di Costanzo GG, Tortora R, D’Adamo G, De Luca M, Lampasi F, Addario L, et al. Radiofrequency ablation versus laser ablation for the treatment of small hepatocellular carcinoma in cirrhosis: a randomized trial. J Gastroenterol Hepatol. 2015;30(3):559–65.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Interventional Radiology, European Institute of Oncology, IRCCS, Milan, Italy

    Giovanni Mauri

  2. Department of Ultrasound, First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

    Tian’an Jiang, Qiyu Zhao & Weilu Chai

Authors
  1. Giovanni Mauri
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tian’an Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qiyu Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Weilu Chai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Giovanni Mauri .

Editor information

Editors and Affiliations

  1. Department of Interventional Radiology, Ospedale Regina Apostolorum, Albano Laziale, Rome, Italy

    Claudio Maurizio Pacella

  2. Department of Ultrasound, Zhejiang University, Hangzhou, China

    Tian'an Jiang

  3. Division of Interventional Radiology, European Institute of Oncology, IRCCS, Milan, Italy

    Giovanni Mauri

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Mauri, G., Jiang, T., Zhao, Q., Chai, W. (2020). Retroperitoneal and Abdominal Lesions Laser Ablation. In: Pacella, C., Jiang, T., Mauri, G. (eds) Image-guided Laser Ablation. Springer, Cham. https://doi.org/10.1007/978-3-030-21748-8_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-21748-8_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-21747-1

  • Online ISBN: 978-3-030-21748-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation